DS-6000a

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-6000a, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors [Phase 1]